Garren, Hideki Litigation, Intellectual Property, Attorneys, SEC Filings, and Other Public Records

Add a document

Date Recorded	Party	Role	Document Type	Document No.	Invention Title

5/12/2020	Tolerion, Inc.	Assignee	Application Publication	16197578 20190315827	Compositions And Methods For Treatment Of Type 1 Diabetes Compositions And Methods For Treatment Of Type 1 Diabetes

10/9/2019	Tolerion, Inc.	Assignee	Application Publication	13376345 20180092991	Compositions And Methods For Treatment Of Insulin-dependent Diabetes Mel... Compositions And Methods For Treatment Of Insulin-dependent Diabetes Mel...

7/14/2016	Tolerion	Assignee	Application Publication	14888639 20160068585	Compositions And Methods For Treatment Of Type 1 Diabetes Compositions And Methods For Treatment Of Type 1 Diabetes

11/9/2009	Bayhill Therapeutics, Inc.	Assignee	Application Publication	12304628 20100048679	Polynucleotide Therapy Polynucleotide Therapy

12/18/2007	Bayhill Therapeutics, Inc.	Assignee	Application Publication	12304459 20100130593	Methods And Immune Modulator Nucleic Acid Compositions For Preventing An... Methods And Immune Modulator Nucleic Acid Compositions For Preventing An...

12/18/2007	Bayhill Therapeutics, Inc.	Assignee	Application Publication	12304628 20100048679	Polynucleotide Therapy Polynucleotide Therapy

12/18/2007	Bayhill Therapeutics, Inc.	Assignee	Application Publication	12089190 20100160415	Compositions And Methods For Treatment Of Autoimmune Disease Compositions And Methods For Treatment Of Autoimmune Disease

6/1/2007	Board Of Trustees Of The Leland Stanford...	Assignee	Application Publication Patent	10556756 20070280954 7867976	Nogo Epitopic Fragments For Modulating Immune Response Nogo Epitopic Fragments For Modulating Immune Response Nogo Epitopic Fragments For Modulating Immune Response

3/30/2007	Bayhill Therapeutics, Inc.	Assignee	Application Publication Patent	10589067 20070275899 7585843	Treatment Of Demyelinating Autoimmune Disease With Modified Ordered Pept... Treatment Of Demyelinating Autoimmune Disease With Modified Ordered Pept... Treatment Of Demyelinating Autoimmune Disease With Modified Ordered Pept...

3/8/2004	Bayhill Therapeutics, Inc.	Assignee	Application Publication Patent	10524643 20050261215 7811813	Methods And Immune Modulatory Nucleic Acid Compositions For Preventing A... Methods And Immune Modulatory Nucleic Acid Compositions For Preventing A... Methods And Immune Modulatory Nucleic Acid Compositions For Preventing A...

9/25/2003	Bayhill Therapeutics, Inc.	Assignee	Application Publication	10404679 20030229044	Use of statins and other immunomodulatory agents in the treatment of aut... Use of statins and other immunomodulatory agents in the treatment of aut...

7/25/2003	The Board Of Trustees Of The Leland Stan...	Assignee	Application Publication	10404679 20030229044	Use of statins and other immunomodulatory agents in the treatment of aut... Use of statins and other immunomodulatory agents in the treatment of aut...

4/21/2003	Board Of Trustees Of The Leland Stanford...	Assignee	Application Publication Patent	10302098 20030148983 7544669	Polynucleotide Therapy Polynucleotide Therapy Polynucleotide Therapy

7/16/2002	Board Of Trustees Of The Leland Stanford...	Assignee	Application Publication Patent	10120578 20030003516 7785819	Therapeutic And Diagnostic Uses Of Antibody Specificity Profiles Therapeutic And Diagnostic Uses Of Antibody Specificity Profiles Therapeutic And Diagnostic Uses Of Antibody Specificity Profiles

12/27/2001	The Board Of Trustees Of The Leland Stan...	Assignee	Application Publication Patent	09947770 20020068715 7030098	Dna Vaccination With Plasmid Encoded Alutoantigens For Treatment Of Mult... Dna Vaccination With Plasmid Encoded Alutoantigens For Treatment Of Mult... Dna Vaccination With Plasmid Encoded Alutoantigens For Treatment Of Mult...

15 Rows Total

Garren, Hideki has not been involved in any trademark assignment transactions in the PlainSite database.

Incoming Payments

This individual has not disclosed any incoming payments from lobbying groups.

Outgoing Payments

This individual has not disclosed any outgoing payments to lobbying groups.